Selinexor (KPT-330) Plus FLAG-Ida for the Treatment of Relapsing/Refractory AML
Clinical trial NCT03661515 · COMPLETED
Trial details
- NCT number
- NCT03661515
- Sponsor
- PETHEMA Foundation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-17
- Primary completion
- 2019-07-15
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.